Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹1,705 Cr₹8.68 Cr₹48 Cr₹16 Cr₹-36 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA is ₹1,705 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹1,705 Cr
Mar2024₹8.68 Cr
Mar2023₹48 Cr
Mar2022₹16 Cr
Mar2021₹-36 Cr

How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹1,705 Cr
19,538.48
Mar2024 ₹8.68 Cr
-81.74
Mar2023 ₹48 Cr
191.02
Mar2022 ₹16 Cr
Positive
Mar2021 ₹-36 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,419.8 Cr -0.6% 11% -1.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,725.0 Cr -3.2% 10.5% 9.3% Stock Analytics
DIVIS LABORATORIES ₹182,775.0 Cr 0.8% 9.5% 4.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹151,764.0 Cr 2% 9.9% 35.4% Stock Analytics
CIPLA ₹113,007.0 Cr -1.9% 13.3% -6% Stock Analytics
DR REDDYS LABORATORIES ₹109,098.0 Cr -1.8% 7.4% 8.2% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-0.6%

11%

-1.8%

SENSEX

0.2%

-4.9%

-8.4%


You may also like the below Video Courses